Other
Cumulative Cost Basis
Amgen Cumulative Cost Basis increased by 34.7% to $11.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.3%, from $8.30B to $11.48B. Over 5 years (FY 2020 to FY 2025), Cumulative Cost Basis shows a downward trend with a -2.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
How to read this metric
Provides a stable reference point for the scale of the bank's investment activities and historical capital deployment.
Detailed definition
The cumulative cost basis represents the original purchase price or historical cost of assets or liabilities before any...
Peer comparison
Universal accounting concept used by all financial institutions to track historical investment scale.
Metric ID:
cumulative_cost_basisHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.16B | $12.28B | $7.30B | $5.85B | $6.41B | $10.92B | $4.34B | $31.07B | $33.62B | $34.21B | $10.40B | $9.24B | $8.81B | $8.58B | $11.49B | $8.30B | $7.49B | $8.71B | $8.53B | $11.48B |
| QoQ Change | — | +71.5% | -40.5% | -19.9% | +9.6% | +70.3% | -60.3% | +616.6% | +8.2% | +1.8% | -69.6% | -11.2% | -4.6% | -2.7% | +33.9% | -27.7% | -9.8% | +16.3% | -2.1% | +34.7% |
| YoY Change | — | — | — | — | -10.4% | -11.0% | -40.6% | +430.8% | +424.2% | +213.2% | +140.0% | -70.3% | -73.8% | -74.9% | +10.4% | -10.1% | -15.0% | +1.5% | -25.8% | +38.3% |
Range$4.34B – $34.21B
CAGR+10.5%
Avg YoY Growth+57.9%
Median YoY Growth-10.3%
Cumulative Cost Basis at Other Companies
Frequently Asked Questions
- What is Amgen's cumulative cost basis?
- Amgen (AMGN) reported cumulative cost basis of $11.48B in Q1 2026.
- How has Amgen's cumulative cost basis changed year-over-year?
- Amgen's cumulative cost basis increased by 38.3% year-over-year, from $8.30B to $11.48B.
- What is the long-term trend for Amgen's cumulative cost basis?
- Over 5 years (2020 to 2025), Amgen's cumulative cost basis has grown at a -2.8% compound annual growth rate (CAGR), from $9.84B to $8.53B.
- What does cumulative cost basis mean?
- The original total cost of assets or liabilities before any accounting adjustments.